Abstract

Discontinuing Disease-Modifying Therapies in Nonactive Secondary Progressive MS: Review of the Evidence

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call